Literature DB >> 33419458

Persistence of intramyocardially transplanted murine induced pluripotent stem cell-derived cardiomyocytes from different developmental stages.

Gabriel Peinkofer1,2,3, Martina Maass4,5, Kurt Pfannkuche6,7,8,9, Agapios Sachinidis6,9, Stephan Baldus4, Jürgen Hescheler6, Tomo Saric6, Marcel Halbach4.   

Abstract

BACKGROUND: Induced pluripotent stem cell-derived cardiomyocytes (iPSC-CM) are regarded as promising cell type for cardiac cell replacement therapy, but it is not known whether the developmental stage influences their persistence and functional integration in the host tissue, which are crucial for a long-term therapeutic benefit. To investigate this, we first tested the cell adhesion capability of murine iPSC-CM in vitro at three different time points during the differentiation process and then examined cell persistence and quality of electrical integration in the infarcted myocardium in vivo.
METHODS: To test cell adhesion capabilities in vitro, iPSC-CM were seeded on fibronectin-coated cell culture dishes and decellularized ventricular extracellular matrix (ECM) scaffolds. After fixed periods of time, stably attached cells were quantified. For in vivo experiments, murine iPSC-CM expressing enhanced green fluorescent protein was injected into infarcted hearts of adult mice. After 6-7 days, viable ventricular tissue slices were prepared to enable action potential (AP) recordings in transplanted iPSC-CM and surrounding host cardiomyocytes. Afterwards, slices were lysed, and genomic DNA was prepared, which was then used for quantitative real-time PCR to evaluate grafted iPSC-CM count.
RESULTS: The in vitro results indicated differences in cell adhesion capabilities between day 14, day 16, and day 18 iPSC-CM with day 14 iPSC-CM showing the largest number of attached cells on ECM scaffolds. After intramyocardial injection, day 14 iPSC-CM showed a significant higher cell count compared to day 16 iPSC-CM. AP measurements revealed no significant difference in the quality of electrical integration and only minor differences in AP properties between d14 and d16 iPSC-CM.
CONCLUSION: The results of the present study demonstrate that the developmental stage at the time of transplantation is crucial for the persistence of transplanted iPSC-CM. iPSC-CM at day 14 of differentiation showed the highest persistence after transplantation in vivo, which may be explained by a higher capability to adhere to the extracellular matrix.

Entities:  

Keywords:  Cell persistence; Cell therapy; Induced pluripotent stem cell-derived cardiomyocytes

Mesh:

Year:  2021        PMID: 33419458      PMCID: PMC7792075          DOI: 10.1186/s13287-020-02089-5

Source DB:  PubMed          Journal:  Stem Cell Res Ther        ISSN: 1757-6512            Impact factor:   6.832


  54 in total

1.  Neonatal murine heart slices. A robust model to study ventricular isometric contractions.

Authors:  Frank Pillekamp; Marcel Halbach; Michael Reppel; Olga Rubenchyk; Kurt Pfannkuche; Jiao-Ya Xi; Wilhelm Bloch; Narayanswami Sreeram; Konrad Brockmeier; Juergen Hescheler
Journal:  Cell Physiol Biochem       Date:  2007

2.  Magnetic targeting of cardiosphere-derived stem cells with ferumoxytol nanoparticles for treating rats with myocardial infarction.

Authors:  Adam C Vandergriff; Taylor M Hensley; Eric T Henry; Deliang Shen; Shirena Anthony; Jinying Zhang; Ke Cheng
Journal:  Biomaterials       Date:  2014-07-16       Impact factor: 12.479

3.  Increasing transplanted cell survival with cell-based angiogenic gene therapy.

Authors:  Terrence M Yau; Christopher Kim; Dawn Ng; Guangming Li; Yaoguang Zhang; Richard D Weisel; Ren-Ke Li
Journal:  Ann Thorac Surg       Date:  2005-11       Impact factor: 4.330

4.  Cellular cardiomyoplasty improves survival after myocardial injury.

Authors:  Wilhelm Roell; Zhong J Lu; Wilhelm Bloch; Sharon Siedner; Klaus Tiemann; Ying Xia; Eva Stoecker; Michaela Fleischmann; Heribert Bohlen; Robert Stehle; Eugen Kolossov; Gottfried Brem; Klaus Addicks; Gabriele Pfitzer; Armin Welz; Juergen Hescheler; Bernd K Fleischmann
Journal:  Circulation       Date:  2002-05-21       Impact factor: 29.690

5.  Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells.

Authors:  Lei Ye; Ying-Hua Chang; Qiang Xiong; Pengyuan Zhang; Liying Zhang; Porur Somasundaram; Mike Lepley; Cory Swingen; Liping Su; Jacqueline S Wendel; Jing Guo; Albert Jang; Daniel Rosenbush; Lucas Greder; James R Dutton; Jianhua Zhang; Timothy J Kamp; Dan S Kaufman; Ying Ge; Jianyi Zhang
Journal:  Cell Stem Cell       Date:  2014-12-04       Impact factor: 24.633

6.  Long-Term Engraftment of Human Cardiomyocytes Combined with Biodegradable Microparticles Induces Heart Repair.

Authors:  Laura Saludas; Elisa Garbayo; Manuel Mazo; Beatriz Pelacho; Gloria Abizanda; Olalla Iglesias-Garcia; Angel Raya; Felipe Prósper; María J Blanco-Prieto
Journal:  J Pharmacol Exp Ther       Date:  2019-02-06       Impact factor: 4.030

Review 7.  Regulation of voltage-gated K+ channel expression in the developing mammalian myocardium.

Authors:  J M Nerbonne
Journal:  J Neurobiol       Date:  1998-10

8.  Dynamic tracking during intracoronary injection of 18F-FDG-labeled progenitor cell therapy for acute myocardial infarction.

Authors:  Brendan Doyle; Brad J Kemp; Panithaya Chareonthaitawee; Cynthia Reed; Jeffrey Schmeckpeper; Paul Sorajja; Stephen Russell; Philip Araoz; Stephen J Riederer; Noel M Caplice
Journal:  J Nucl Med       Date:  2007-10       Impact factor: 10.057

9.  Electrophysiological maturation and integration of murine fetal cardiomyocytes after transplantation.

Authors:  Marcel Halbach; Kurt Pfannkuche; Frank Pillekamp; Agnieszka Ziomka; Tobias Hannes; Michael Reppel; Juergen Hescheler; Jochen Müller-Ehmsen
Journal:  Circ Res       Date:  2007-07-19       Impact factor: 17.367

10.  Disruption of epithelial cell-matrix interactions induces apoptosis.

Authors:  S M Frisch; H Francis
Journal:  J Cell Biol       Date:  1994-02       Impact factor: 10.539

View more
  1 in total

1.  From genome editing to blastocyst complementation: A new horizon in heart transplantation?

Authors:  Igor E Konstantinov; Gregory King; Enzo R Porrello
Journal:  JTCVS Tech       Date:  2022-01-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.